Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NCCAM director

This article was originally published in The Tan Sheet

Executive Summary

The new director-designate of the National Institutes of Health National Center for Complementary & Alternative Medicine reportedly is Stephen Straus, MD, Chief of the Laboratory of Clinical Investigation at the National Institute of Allergy & Infectious Diseases. The appointment is pending final administrative approval. Under House Appropriations/HHS subcommittee Chair John Porter's (R-Ill.) mark of the FY 2000 spending bill, NCCAM's budget would receive a $17.8 mil. increase over the current funding level, a 36% hike, for a total appropriation of $68 mil. President Clinton's FY 2000 budget proposal requested the center be funded at $50.2 mil. In addition, bill language would provide NCCAM with direct appropriations rather than be channeled through the NIH Office of the Director

You may also be interested in...



NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers

The National Center for Complementary & Alternative Medicine is sponsoring a multicenter study to test the safety, efficacy and tolerability of ginkgo biloba for the prevention of dementia in the elderly, the center announced Sept. 30.

NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers

The National Center for Complementary & Alternative Medicine is sponsoring a multicenter study to test the safety, efficacy and tolerability of ginkgo biloba for the prevention of dementia in the elderly, the center announced Sept. 30.

NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers

The National Center for Complementary & Alternative Medicine is sponsoring a multicenter study to test the safety, efficacy and tolerability of ginkgo biloba for the prevention of dementia in the elderly, the center announced Sept. 30.

Topics

UsernamePublicRestriction

Register

PS090360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel